Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 10.48%97.46B | -0.29%369.44B | -6.75%88.22B | -11.27%370.51B | -10.43%90.34B | -10.26%92.53B | -19.28%93.04B | -3.78%94.6B | 4.09%417.55B | -1.02%100.87B |
| Cost of revenue | -0.34%62.39B | -4.45%256.11B | -14.42%62.61B | -7.58%268.04B | -13.47%65.72B | -4.76%65.88B | -18.74%63.28B | 9.14%73.16B | 3.19%290.03B | 4.99%75.96B |
| Gross profit | 36.93%35.07B | 10.60%113.33B | 19.43%25.61B | -19.64%102.47B | -1.16%24.62B | -21.47%26.65B | -20.41%29.76B | -31.46%21.45B | 6.19%127.52B | -15.72%24.91B |
| Operating expense | 21.76%17.44B | 19.68%65.71B | 7.95%14.32B | -0.45%54.9B | 2.03%14B | -2.75%13.77B | -1.45%13.87B | 0.49%13.26B | 11.97%55.15B | 4.24%13.72B |
| Operating profit | 56.15%17.64B | 0.11%47.62B | 38.05%11.3B | -34.26%47.57B | -5.07%10.62B | -34.88%12.88B | -31.85%15.89B | -54.77%8.18B | 2.18%72.36B | -31.75%11.19B |
| Net non-operating interest income (expenses) | -11.67%212M | 126.09%884M | 44.58%240M | 0.77%391M | -104.05%-10M | -61.58%78M | 318.06%157M | 1,560.00%166M | 220.50%388M | 224.75%247M |
| Non-operating interest income | 24.01%563M | 77.76%2.19B | 46.45%454M | 29.01%1.23B | -8.73%324M | -16.57%282M | 68.09%316M | 318.92%310M | 827.18%955M | 944.12%355M |
| Non-operating interest expense | 64.02%351M | 62.68%1.16B | 48.61%214M | 91.89%710M | 87.96%203M | 51.11%204M | 152.38%159M | 125.00%144M | 32.14%370M | 24.14%108M |
| Total other finance cost | ---- | 15.27%151M | ---- | -33.50%131M | ---- | ---- | ---- | ---- | 35.86%197M | --0 |
| Net investment income | -54.71%538M | -70.12%828M | -26.62%1.19B | -6.23%2.77B | 184.21%224M | 191.67%561M | -79.80%367M | -19.69%1.62B | -12.00%2.96B | -141.69%-266M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 35,857.35%24.45B | 0 | -76.95%68M | -75.27%68M | 0 | 0 | 0 | 103.86%295M | 103.56%275M |
| Income from associates and other participating interests | 0 | 0 | 0 | 100.00%2M | 100.00%2M | -1M | 1M | 0 | -50.00%1M | 1M |
| Special income (charges) | -40.72%-1.33B | -499.87%-22.63B | -143.96%-943M | 21.92%-3.77B | -124.47%-4.13B | -66.94%-1.02B | 33.04%-770M | 274.11%2.15B | 38.96%-4.83B | 22.01%-1.84B |
| Less:Impairment of capital assets | --967M | --1.74B | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | -115.48%-146M | -28.03%2.3B | 135.80%943M | -19.78%3.2B | 270.67%4.04B | 68.32%1.02B | -27.36%770M | -313.80%-2.63B | -40.44%3.99B | -49.72%1.09B |
| Less:Write off | --506M | 3,143.80%18.59B | --0 | -32.03%573M | -88.77%84M | --0 | --0 | --489M | -30.79%843M | 297.87%748M |
| Other non-operating income (expenses) | -108.97%-13M | -26.47%300M | -36.96%145M | -23.16%408M | -191.74%-100M | 8.06%67M | -10.97%211M | 86.99%230M | -43.81%531M | -78.83%109M |
| Income before tax | 42.94%17.05B | 8.47%51.45B | -3.37%11.93B | -33.84%47.44B | -31.31%6.67B | -33.21%12.56B | -34.34%15.86B | -35.13%12.34B | 21.01%71.7B | 33.76%9.72B |
| Income tax | 37.56%4.17B | 10.93%17.4B | -39.47%3.03B | -18.68%15.69B | 65.35%2.55B | -54.55%2.96B | -13.80%5.17B | -4.45%5.01B | 9.05%19.29B | -54.60%1.54B |
| Net income | 44.77%12.88B | 7.25%34.05B | 21.27%8.9B | -39.43%31.75B | -49.57%4.12B | -21.93%9.6B | -41.12%10.69B | -46.79%7.34B | 26.10%52.41B | 111.52%8.17B |
| Net income continuous operations | 44.78%12.88B | 7.25%34.05B | 21.27%8.9B | -39.42%31.75B | -49.57%4.12B | -21.92%9.6B | -41.12%10.69B | -46.79%7.34B | 26.10%52.41B | 111.55%8.17B |
| Noncontrolling interests | 89.74%148M | 33.59%346M | 69.57%78M | 14.60%259M | -30.77%27M | 73.68%99M | 50.00%87M | -36.11%46M | -31.72%226M | -46.58%39M |
| Net income attributable to the company | 44.37%12.73B | 7.03%33.7B | 20.97%8.82B | -39.66%31.49B | -49.64%4.1B | -22.38%9.5B | -41.41%10.6B | -46.85%7.29B | 26.57%52.19B | 114.56%8.13B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 44.37%12.73B | 7.03%33.7B | 20.97%8.82B | -39.66%31.49B | -49.64%4.1B | -22.38%9.5B | -41.41%10.6B | -46.85%7.29B | 26.57%52.19B | 114.56%8.13B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 44.48%45.585 | 7.04%120.66 | 20.90%31.55 | -39.68%112.72 | -49.66%14.655 | -22.40%34.015 | -41.43%37.955 | -46.87%26.095 | 26.54%186.865 | 114.44%29.11 |
| Diluted earnings per share | 44.91%42.88 | 0.65%113.095 | 13.39%29.59 | -39.87%112.37 | -49.66%14.655 | -22.41%34.0136 | -41.43%37.955 | -46.87%26.095 | 26.54%186.865 | 114.46%29.11 |
| Dividend per share | 0 | 0.00%20 | 0 | 0.00%20 | 0.00%10 | 0 | 0.00%10 | 0 | 14.29%20 | 0.00%10 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |